Annual CFO
-$16.71 M
-$6.86 M-69.61%
December 1, 2024
Summary
- As of March 10, 2025, VRPX annual cash flow from operations is -$16.71 million, with the most recent change of -$6.86 million (-69.61%) on December 1, 2024.
- During the last 3 years, VRPX annual CFO has fallen by -$2.17 million (-14.92%).
- VRPX annual CFO is now -1376.67% below its all-time high of -$1.13 million, reached on December 31, 2019.
Performance
VRPX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.87 M
+$1.60 M+35.77%
December 1, 2024
Summary
- As of March 10, 2025, VRPX quarterly cash flow from operations is -$2.87 million, with the most recent change of +$1.60 million (+35.77%) on December 1, 2024.
- Over the past year, VRPX quarterly CFO has stayed the same.
- VRPX quarterly CFO is now -1803.65% below its all-time high of -$150.80 thousand, reached on December 31, 2020.
Performance
VRPX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$16.71 M
+$140.80 K+0.84%
December 1, 2024
Summary
- As of March 10, 2025, VRPX TTM cash flow from operations is -$16.71 million, with the most recent change of +$140.80 thousand (+0.84%) on December 1, 2024.
- Over the past year, VRPX TTM CFO has stayed the same.
- VRPX TTM CFO is now -7414.79% below its all-time high of -$222.40 thousand, reached on March 1, 2020.
Performance
VRPX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VRPX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -69.6% | 0.0% | 0.0% |
| 3 y3 years | -14.9% | +41.7% | -14.9% |
| 5 y5 years | -1376.7% | +39.5% | -71.0% |
VRPX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.6% | +6.3% | -83.2% | +62.9% | -98.7% | +21.2% |
| 5 y | 5-year | -1376.7% | +6.3% | -1803.7% | +62.9% | -7414.8% | +21.2% |
| alltime | all time | -1376.7% | +6.3% | -1803.7% | +62.9% | -7414.8% | +21.2% |
Virpax Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$16.71 M(+69.6%) | -$2.87 M(-35.8%) | -$16.71 M(-0.8%) |
| Sep 2024 | - | -$4.47 M(+171.9%) | -$16.85 M(+12.1%) |
| Jun 2024 | - | -$1.64 M(-78.7%) | -$15.04 M(-3.5%) |
| Mar 2024 | - | -$7.73 M(+156.7%) | -$15.57 M(+58.1%) |
| Dec 2023 | -$9.85 M(-44.8%) | -$3.01 M(+13.6%) | -$9.85 M(+17.2%) |
| Sep 2023 | - | -$2.65 M(+21.4%) | -$8.41 M(-25.3%) |
| Jun 2023 | - | -$2.18 M(+8.7%) | -$11.26 M(-18.5%) |
| Mar 2023 | - | -$2.01 M(+28.1%) | -$13.81 M(-22.6%) |
| Dec 2022 | -$17.85 M | -$1.57 M(-71.5%) | -$17.85 M(-15.8%) |
| Sep 2022 | - | -$5.50 M(+16.1%) | -$21.20 M(+3.7%) |
| Jun 2022 | - | -$4.74 M(-21.7%) | -$20.45 M(+16.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.04 M(+22.8%) | -$17.51 M(+20.4%) |
| Dec 2021 | -$14.54 M(+950.1%) | -$4.92 M(+3.8%) | -$14.54 M(+48.8%) |
| Sep 2021 | - | -$4.74 M(+163.8%) | -$9.77 M(+72.3%) |
| Jun 2021 | - | -$1.80 M(-41.6%) | -$5.67 M(+33.7%) |
| Mar 2021 | - | -$3.08 M(+1942.6%) | -$4.24 M(+206.4%) |
| Dec 2020 | -$1.38 M(+22.4%) | -$150.80 K(-76.6%) | -$1.38 M(+12.2%) |
| Sep 2020 | - | -$643.40 K(+74.7%) | -$1.23 M(+108.9%) |
| Jun 2020 | - | -$368.20 K(+65.6%) | -$590.60 K(+165.6%) |
| Mar 2020 | - | -$222.40 K | -$222.40 K |
| Dec 2019 | -$1.13 M(-37.1%) | - | - |
| Dec 2018 | -$1.80 M | - | - |
FAQ
- What is Virpax Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual CFO year-on-year change?
- What is Virpax Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly CFO year-on-year change?
- What is Virpax Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals TTM CFO year-on-year change?
What is Virpax Pharmaceuticals annual cash flow from operations?
The current annual CFO of VRPX is -$16.71 M
What is the all time high annual CFO for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual cash flow from operations is -$1.13 M
What is Virpax Pharmaceuticals annual CFO year-on-year change?
Over the past year, VRPX annual cash flow from operations has changed by -$6.86 M (-69.61%)
What is Virpax Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of VRPX is -$2.87 M
What is the all time high quarterly CFO for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly cash flow from operations is -$150.80 K
What is Virpax Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, VRPX quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Virpax Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of VRPX is -$16.71 M
What is the all time high TTM CFO for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high TTM cash flow from operations is -$222.40 K
What is Virpax Pharmaceuticals TTM CFO year-on-year change?
Over the past year, VRPX TTM cash flow from operations has changed by $0.00 (0.00%)